Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

SGLT2 Inhibitors' Warning On Ketoacidosis Recommends Drug Holidays

This article was originally published in The Pink Sheet Daily

Executive Summary

Sponsors must also conduct another post-marketing study.


Related Content

AstraZeneca Diabetes Combo Needs More Clinical Data, FDA Says
FDA Warning On SGLT-2 Drugs Raises Specter Of Labeling Change


Related Companies